Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 18 of the 39 sources its claims cite were checked for support.

Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans

Open access

Abstract

In Candida albicans , Upc2 is a zinc-cluster transcription factor that targets genes, including those of the ergosterol biosynthesis pathway. To date, three documented UPC2 gain-of-function (GOF) mutations have been recovered from fluconazole-resistant clinical isolates that contribute to an increase in ERG11 expression and decreased fluconazole susceptibility. In a group of 63 isolates with reduced susceptibility to fluconazole, we found that 47 overexpressed ERG11 by at least 2-fold over the average expression levels in 3 unrelated fluconazole-susceptible strains. Of those 47 isolates, 29 contained a mutation in UPC2 , whereas the remaining 18 isolates did not. Among the isolates containing mutations in UPC2 , we recovered eight distinct mutations resulting in putative single amino acid substitutions: G648D, G648S, A643T, A643V, Y642F, G304R, A646V, and W478C. Seven of these resulted in increased ERG11 expression, increased cellular ergosterol, and decreased susceptibility to fluconazole compared to the results for the wild-type strain. Genome-wide transcriptional analysis was performed for the four strongest Upc2 amino acid substitutions (A643V, G648D, G648S, and Y642F). Genes commonly upregulated by all four mutations included those involved in ergosterol biosynthesis, in oxidoreductase activity, the major facilitator efflux pump encoded by the MDR1 gene, and the uncharacterized ATP binding cassette transporter CDR11 . These findings demonstrate that gain-of-function mutations in UPC2 are more prevalent among clinical isolates than previously thought and make a significant contribution to azole antifungal resistance, but the findings do not account for ERG11 overexpression in all such isolates of C. albicans .

Overview

CoChat Summary

TL;DR

In a collection of azole-resistant *Candida albicans* clinical isolates, *ERG11* overexpression was common, and many such isolates carried gain-of-function mutations in *UPC2*. Seven of eight recovered Upc2 substitutions increased *ERG11* expression, cellular ergosterol, and resistance to fluconazole and other ergosterol biosynthesis inhibitors, but *UPC2* mutations did not explain all *ERG11* overexpression.

Key findings

  • Among 63 isolates with reduced fluconazole susceptibility, 47 overexpressed *ERG11* by at least 2-fold; 29 of those 47 had a *UPC2* mutation, while 18 did not.
  • Eight distinct putative Upc2 amino acid substitutions were recovered: G648D, G648S, A643T, A643V, Y642F, G304R, A646V, and W478C; seven increased *ERG11* expression, increased cellular ergosterol, and decreased fluconazole susceptibility, whereas G304R did not.
  • In constructed strains, homozygous mutant *UPC2* alleles generally produced stronger *ERG11* expression and lower azole susceptibility than heterozygous strains; G648D gave the highest *ERG11* expression.
  • Microarray analysis of four strong *UPC2* GOF alleles (A643V, G648D, G648S, Y642F) found 61 commonly upregulated and 5 commonly downregulated genes, including ergosterol biosynthesis genes, oxidoreductase genes, *MDR1*, and *CDR11*.

Methods

  • Used 72 unrelated clinical *C. albicans* isolates from the University of Iowa, including oral and nonoral sources; fluconazole resistance was defined as MIC ≥ 16 µg/ml, and *ERG11*, *CDR1*, *CDR2*, and *MDR1* expression was measured by qRT-PCR.
  • Sequenced *UPC2* alleles from isolates overexpressing *ERG11*, then constructed *C. albicans* strains expressing mutant *UPC2* alleles alone, as heterozygotes with wild-type *UPC2*, and as homozygotes using the SAT1-flipper system.
  • Measured antifungal MICs by modified CLSI broth microdilution and Etest, quantified cellular ergosterol spectrophotometrically, and performed genome-wide transcriptional profiling with Affymetrix *C. albicans* custom expression arrays.

Limitations

  • The paper states that it cannot define the clinical implications of fluconazole resistance among nonoral isolates, that *ERG11* expression levels in clinical isolates did not always match those in laboratory strains constructed with the same *UPC2* allele, and that not all *ERG11* overexpression was explained by *UPC2* GOF mutations.
  • The paper states that other regulators of ergosterol biosynthesis, *UPC2* promoter mutation, *UPC2* duplication, trans-acting mutations, or aneuploidy such as chromosome 5 duplication/chr5L isochromosome may contribute, and that combinatorial effects of activated *UPC2* with mutant *ERG11* alleles were not explored.
  • Evident from the text: most mechanistic work used laboratory-constructed strains rather than the original clinical isolates, so the direct clinical impact of each individual *UPC2* allele remains inferential.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/ec.00215-12

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

14 Valid · 2 Not valid · 10 Not checked · 90 Own results and interpretations

61 more claims

Create a free account to see all 116 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 31
  • It may state two separate claims as one. 27
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

6 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 32 references

Cited by

See all 243

Metadata

Authors
Flowers, S. A., Barker, K. S., Berkow, E. L., Toner, G., Chadwick, S. G., Gygax, S. E., Morschhäuser, J., & Rogers, P. D.
Affiliations
  • University of Tennessee Health Science Center (US)
  • Medical Diagnostic Laboratories (United States) (US)
  • University of Würzburg (DE)
Venue
Eukaryotic Cell
Published
2012-10
Volume
11
Issue
10
Pages
1289-1299
ISSN
  • 1535-9778 (ISSN-L)
  • 1535-9786
OpenAlex
W2169755129
Cited by
239
References
32
Citations by year
2026: 14 · 2025: 12 · 2024: 25 · 2023: 22 · 2022: 19 · 2021: 22 · 2020: 21 · 2019: 23 · 2018: 11 · 2017: 20 · 2016: 9 · 2015: 14 · 2014: 16 · 2013: 11
FWCI
9.05
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Eukaryotic Cell (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R01AI058145)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords
Candida albicans, UPC2, ERG11, fluconazole resistance, azole resistance, gain-of-function mutations, zinc cluster transcription factors, ergosterol biosynthesis, transcriptional regulation, clinical isolates, antifungal resistance
MeSH terms
Antifungal Agents, Candida albicans, Cytochrome P-450 Enzyme System, Ergosterol, Fungal Proteins, Transcription Factors, Transcription, Genetic, Fluconazole, Up-Regulation, Genome, Fungal, Mutation, Missense, ATP Binding Cassette Transporter, Subfamily B, Member 1, Drug Resistance, Fungal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-11-02, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-02 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans. https://app.cochat.ai/papers/10.1128/ec.00215-12
The paper
Flowers, S. A., Barker, K. S., Berkow, E. L., Toner, G., Chadwick, S. G., Gygax, S. E., Morschhäuser, J., & Rogers, P. D. (2012). Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans. Eukaryotic Cell. https://doi.org/10.1128/ec.00215-12

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.